References
- Janciauskiene SM, Bals R, Koczulla R, Vogelmeier C, Köhnlein T, Welte T. The discovery of a1-antitrypsin and its role in health and disease. Respir. Med. 105(8), 1129–1139 (2011).
- Fermi C, Pernossi L. Untersuchungen uber die enzyme, vergleichende studie. Z. Hyg. Infektieionskr. 18, 83–89 (1894).
- Schultze H, Goilner I, Heide K, Schoenenberger M, Schwick G. Kenntnis der α-globulin der menschlichen nirmal serums. Z. Naturforsch 10, 463 (1955).
- Eriksson S. A 30 year perspective on α1-antitrypsin deficiency. Chest 110, 2375–2425 (1996).
- Ekeowa UI, Marciniak SJ, Lomas DA. a(1)-antitrypsin deficiency and inflammation. Expert Rev. Clin. Immunol. 7(2), 243–252 (2011).
- Silverman EK, Sandhaus RA. Clinical practice. α1-antitrypsin deficiency. N. Engl. J. Med. 360(26), 2749–2757 (2009).
- Pott GB, Chan ED, Dinarello CA, Shapiro L. α-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85(5), 886–895 (2009).
- Tawara I, Sun Y, Lewis EC et al. α-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc. Natl Acad. Sci. USA 109(2), 564–569 (2012).
- Marcondes AM, Li X, Tabellini L et al. Inhibition of IL-32 activation by a-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood 118(18), 5031–5039 (2011).
- Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. α1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl Acad. Sci. USA 102(34), 12153–12158 (2005).
- Lewis EC, Mizrahi M, Toledano M et al. α1-antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl Acad. Sci. USA 105(42), 16236–16241 (2008).
- Koulmanda M, Bhasin M, Hoffman L et al. Curative and β-cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl Acad. Sci. USA 105(42), 16242–16247 (2008).
- Pahl HL, Baeuerle PA. The ER-overload response: activation of NF-κB. Trends Biochem. Sci. 22(2), 63–67 (1997).
- Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115(10), 2656–2664 (2005).
- Tawara I, Sun Y, Lewis EC et al. α-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc. Natl Acad. Sci. USA 109(2), 564–569 (2012).
- Janciauskiene SM, Nita IM, Stevens T. α1-antitrypsin, old dog, new tricks. α1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem. 282(12), 8573–8582 (2007).
- Subramaniyam D, Zhou H, Liang M, Welte T, Mahadeva R, Janciauskiene S. Cholesterol rich lipid raft microdomains are gateway for acute phase protein, SERPINA1. Int. J. Biochem. Cell Biol. 42(9), 1562–1570 (2010).
- Perlmutter DH, Punsal PI. Distinct and additive effects of elastase and endotoxin on expression of α1 proteinase inhibitor in mononuclear phagocytes. J. Biol. Chem. 263(31), 16499–16503 (1988).
- Knoell DL, Ralston DR, Coulter KR, Wewers MD. α1-antitrypsin and protease complexation is induced by lipopolysaccharide, interleukin-1β, and tumor necrosis factor-α in monocytes. Am. J. Respir. Crit. Care Med. 157(1), 246–255 (1998).
- Lee SJ, Zahrieh D, Agura E et al. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood 104(5), 1559–1564 (2004).